Pulse Biosciences (PLSE) Competitors $16.49 +0.19 (+1.17%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PLSE vs. IRTC, BLCO, SLNO, TMDX, PRCT, NVST, NVCR, LIVN, ENOV, and LMATShould you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), NovoCure (NVCR), LivaNova (LIVN), Enovis (ENOV), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. Pulse Biosciences vs. iRhythm Technologies Bausch + Lomb Soleno Therapeutics TransMedics Group PROCEPT BioRobotics Envista NovoCure LivaNova Enovis LeMaitre Vascular iRhythm Technologies (NASDAQ:IRTC) and Pulse Biosciences (NASDAQ:PLSE) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, community ranking, earnings, profitability, risk and institutional ownership. Which has more risk & volatility, IRTC or PLSE? iRhythm Technologies has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.6, meaning that its share price is 60% more volatile than the S&P 500. Is IRTC or PLSE more profitable? Pulse Biosciences has a net margin of 0.00% compared to iRhythm Technologies' net margin of -19.14%. Pulse Biosciences' return on equity of -96.89% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-19.14% -118.83% -11.34% Pulse Biosciences N/A -96.89%-74.83% Which has higher earnings and valuation, IRTC or PLSE? Pulse Biosciences has lower revenue, but higher earnings than iRhythm Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$618.59M7.30-$123.41M-$3.14-45.04Pulse Biosciences$700K1,565.95-$42.21MN/AN/A Do institutionals & insiders believe in IRTC or PLSE? 76.9% of Pulse Biosciences shares are owned by institutional investors. 1.1% of iRhythm Technologies shares are owned by company insiders. Comparatively, 71.5% of Pulse Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts rate IRTC or PLSE? iRhythm Technologies currently has a consensus target price of $128.55, suggesting a potential downside of 9.11%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, equities analysts clearly believe iRhythm Technologies is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.91Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in IRTC or PLSE? iRhythm Technologies received 166 more outperform votes than Pulse Biosciences when rated by MarketBeat users. Likewise, 66.19% of users gave iRhythm Technologies an outperform vote while only 63.50% of users gave Pulse Biosciences an outperform vote. CompanyUnderperformOutperformiRhythm TechnologiesOutperform Votes41366.19% Underperform Votes21133.81% Pulse BiosciencesOutperform Votes24763.50% Underperform Votes14236.50% Does the media refer more to IRTC or PLSE? In the previous week, iRhythm Technologies had 6 more articles in the media than Pulse Biosciences. MarketBeat recorded 11 mentions for iRhythm Technologies and 5 mentions for Pulse Biosciences. iRhythm Technologies' average media sentiment score of 1.44 beat Pulse Biosciences' score of 0.83 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pulse Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive SummaryiRhythm Technologies beats Pulse Biosciences on 9 of the 16 factors compared between the two stocks. Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLSE vs. The Competition Export to ExcelMetricPulse BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.09B$4.40B$5.19B$8.42BDividend YieldN/A37.68%4.99%4.16%P/E RatioN/A29.3526.3519.59Price / Sales1,565.9553.20386.96120.30Price / CashN/A51.0838.3134.62Price / Book20.126.166.614.47Net Income-$42.21M$67.09M$3.22B$247.85M7 Day Performance-3.30%0.01%0.95%3.32%1 Month Performance-4.32%4.90%6.52%11.04%1 Year Performance124.44%21.53%12.77%5.26% Pulse Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLSEPulse Biosciences0.8654 of 5 stars$16.49+1.2%N/A+112.0%$1.11B$700,000.000.00140Earnings ReportIRTCiRhythm Technologies1.309 of 5 stars$135.76+3.5%$128.55-5.3%+41.3%$4.33B$591.84M-37.301,790Positive NewsHigh Trading VolumeBLCOBausch + Lomb4.2982 of 5 stars$11.37-1.1%$16.14+41.9%-23.6%$4.02B$4.83B-12.4912,500High Trading VolumeSLNOSoleno Therapeutics4.538 of 5 stars$76.49+1.7%$104.67+36.8%+68.9%$3.82BN/A-23.0430Analyst RevisionTMDXTransMedics Group2.0935 of 5 stars$92.21+2.5%$124.20+34.7%-7.6%$3.12B$441.54M98.10210Earnings ReportInsider TradePositive NewsPRCTPROCEPT BioRobotics2.7907 of 5 stars$54.41-2.2%$90.00+65.4%-16.1%$3.01B$249.12M-27.90430NVSTEnvista4.0804 of 5 stars$17.00+0.1%$20.15+18.5%-6.6%$2.88B$2.50B-2.6212,700NVCRNovoCure3.6469 of 5 stars$17.76-2.1%$32.83+84.9%-15.8%$1.98B$621.71M-12.691,320Positive NewsLIVNLivaNova3.7839 of 5 stars$36.28-1.4%$61.17+68.6%-29.1%$1.98B$1.25B86.382,900Analyst ForecastPositive NewsHigh Trading VolumeENOVEnovis3.0614 of 5 stars$34.21-3.1%$58.50+71.0%-31.0%$1.95B$2.11B-15.626,800Earnings ReportAnalyst ForecastAnalyst RevisionPositive NewsLMATLeMaitre Vascular3.3137 of 5 stars$80.44+2.2%$98.14+22.0%+6.4%$1.82B$219.86M43.96490Positive NewsHigh Trading Volume Related Companies and Tools Related Companies IRTC Competitors BLCO Competitors SLNO Competitors TMDX Competitors PRCT Competitors NVST Competitors NVCR Competitors LIVN Competitors ENOV Competitors LMAT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLSE) was last updated on 5/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PLSE Stock Free PLSE Stock Alerts